XML 41 R30.htm IDEA: XBRL DOCUMENT v3.21.2
STOCKHOLDERS' EQUITY (Tables)
9 Months Ended
Sep. 30, 2021
Stockholders' Equity Note [Abstract]  
Schedule of restricted stock granted and exercisable
          Restricted Stock Granted       Restricted Stock Vested  
  Grant date
Price
      Number
Granted
      Weighted
Average
Fair Value per
Share
      Number
Vested
      Weighted
Average
Fair Value per
Share
 
$ 0.049       20,495,000     $ 0.049       10,247,500     $ 0.049  
  0.05       1,000,000       0.050       1,000,000       0.050  
          21,495,000     $ 0.049       11,247,500       0.049  

 

Schedule of fair value of the options granted and issued
   Nine months
ended
September 30,
2021
 
Exercise price   0.05 to 0.24 
Risk free interest rate   0.46% to 0.92 
Expected life   5.0 years 
Expected volatility of underlying stock   213.84 to 215.33 
Expected dividend rate   0%

 

Schedule of warrant activity
   Shares
Underlying
Warrants
   Exercise
price per
share
   Weighted
average
exercise
price
 
Outstanding January 1, 2020   852,775   $ 2.00 to 6.25   $5.10 
Granted   51,188,572    0.05    0.05 
Forfeited/Cancelled   (852,775)      2.00 to 6.25    5.10 
Exercised   
-
    -    
-
 
Outstanding December 31, 2020   51,188,572   $0.05   $0.05 
Granted   66,302,515       0.05 to 0.24    0.16 
Forfeited/Cancelled   (20,000,000)   0.24    0.24 
Exercised   (60,186,982)   0.05    0.05 
Outstanding September 30, 2021   37,304,105    $ 0.05 – 0.1875   $0.12 

 

Schedule of warrants outstanding and exercisable
    Warrants Outstanding   Warrants Exercisable 
Exercise
Price*
   Number
Outstanding
   Weighted
Average
Remaining
Contractual life
in years
   Weighted
Average
Exercise Price
   Number
Exercisable
   Weighted
Average
Exercise Price
   Weighted
Average
Remaining
Contractual
life in years
 
$0.05    10,823,813    4.03         10,823,813         4.03 
 0.15    24,053,625    4.43         24,053,625         4.43 
 0.1875    2,426,667    4.46         2,426,667         4.46 
      37,304,105    4.32    0.12    37,304,105    0.12    4.32 

 

Schedule of fair value of the options granted and issued
    Nine months
ended
September 30,
2021
 
Exercise price   $ 0.15  
Risk free interest rate     1.26 to 1.27 %
Expected life     10.0 years  
Expected volatility of underlying stock     209.3 to 210.4 %
Expected dividend rate     0 %

 

Schedule of the reduction in the exercise price
   Nine months
Ended
September 30,
2021
 
Revised exercise price  $0.15 
Original exercise price  $0.24 
Risk free interest rate   1.27%
Expected life    9.6 years 
Expected volatility of underlying stock   210.4%
Expected dividend rate   0%

Schedule of option activity
   Shares
Underlying
options
   Exercise
price per
share
   Weighted
average
exercise
price
 
Outstanding January 1, 2020   100,000   $0.40   $0.40 
Granted   
-
    -    
-
 
Forfeited/Cancelled   
-
    -    
-
 
Exercised   
-
    -    
-
 
Outstanding December 31, 2020   100,000    0.40    0.40 
Granted   30,416,666    0.15 – 0.24    0.15 
Forfeited/Cancelled   
-
    -    
-
 
Exercised   
-
    -    
-
 
Outstanding September 30, 2021   30,516,666     $ 0.15 to 0.40   $0.15 

 

Schedule of warrants outstanding and exercisable
    Options Outstanding   Options Exercisable 
Exercise
Price*
   Number
Outstanding
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price
   Number
Exercisable
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
life in years
 
 0.15    30,208,333    9.89         15,625,000         9.89 
 0.24    208,333    9.40         208,333         9.40 
 0.40    100,000    7.25         100,000         7.25 
      30,516,666    9.88   $0.15    15,933,333   $0.15    9.87